The California Supreme Court issued a 4-3 decision in T.H. v. Novartis Pharmaceuticals Corporation. In doing so, the Court went further than it has ever gone before in applying the tort of negligent misrepresentation. … ...
Today we filed this amicus brief asking the California Supreme Court to overturn the flawed decision in T.H. v. Novartis, which would essentially impose never-ending tort liability on brand-name drug manufacturers for injuries caused by their generic counterparts. By adopting an expansive theory of liability, the law threatens to drive up the cos ...